Filter
2946
Filtered Results: 2946
Text search:
Inmunización
Featured
Recommendations
264
New Publications
915
Language
Document type
No document type
1676
Guidelines
402
Studies & Reports
355
Strategic & Response Plan
157
Manuals
139
Fact sheets
83
Training Material
49
Situation Updates
42
Resource Platforms
17
Infographics
10
Videos
7
Brochures
5
Online Courses
4
Countries / Regions
India
145
Kenya
102
Global
86
Liberia
76
Nepal
73
Nigeria
73
Uganda
72
Latin America and the Carribbean
63
Sierra Leone
59
Ethiopia
57
Bangladesh
54
Myanmar / Burma
52
Rwanda
48
Tanzania
46
Ghana
42
Africa
40
Paraguay
40
Congo, Democratic Republic of
39
Philippines
38
Zambia
38
Venezuela
37
South Africa
37
Malawi
35
Argentina
29
Syria
28
Brazil
28
Indonesia
28
Lesotho
23
Namibia
23
Ukraine
21
Cambodia
21
Colombia
20
Haiti
20
Western and Central Europe
20
Pakistan
20
Peru
18
Mozambique
18
Zimbabwe
17
South Sudan
17
Senegal
16
Guinea
16
Russia
15
South–East Asia Region
14
Bolivia
14
Yemen
14
Botswana
14
Chile
13
Afghanistan
13
East and Southern Africa
13
Middle East and North Africa
12
Burkina Faso
11
Asia
11
West and Central Africa
11
Germany
10
Eastern Europe and Central Asia
10
Eswatini/ Swaziland
9
Cameroon
8
Lebanon
8
Central African Republic
8
Ecuador
8
Madagascar
8
Jordan
6
Mali
6
Iraq
6
Eastern Europe
5
Albania
4
Western Pacific Region
4
Somalia
4
Guatemala
4
Mexico
3
El Salvador
3
Benin
3
Laos
3
Niger
3
Burundi
3
Côte d’Ivoire / Ivory Coast
3
Moldova
3
Egypt
3
Sudan
3
Palestine
3
Timor Leste/ East Timor
2
Thailand
2
Turkey
2
Togo
2
China
2
Bulgaria
2
Turkmenistan
2
Nicaragua
2
Honduras
2
Angola
2
Chad
2
Libya
2
Tajikistan
1
Gambia
1
Iran
1
Canada
1
Fiji
1
Singapore
1
Qatar
1
USA
1
Guinea-Bissau
1
Hungary
1
Saudi Arabia
1
North America
1
Uruguay
1
Japan
1
Maldives
1
United Kingdom
1
Spain
1
Southern Africa
1
Vietnam
1
Papua New Guinea
1
Sri Lanka
1
Djibouti
1
Romania
1
Slovakia
1
Greece
1
Georgia
1
Poland
1
Authors & Publishers
Publication Years
Category
Countries
1446
Clinical Guidelines
260
Women & Child Health
233
Public Health
147
Key Resources
97
Capacity Building
53
Pharmacy & Technologies
21
Annual Report MEDBOX
1
Toolboxes
COVID-19
427
Rapid Response
125
HIV
112
TB
95
Caregiver
75
AMR
72
Ebola
71
Polio
69
Conflict
68
Pharmacy
58
Disability
43
Global Health Education
42
Mental Health
41
Refugee
40
NTDs
35
Health Financing Toolbox
31
Planetary Health
30
Natural Hazards
23
Cholera
23
Zika
18
NCDs
13
Specific Hazards
2
South Sudan
1
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
This document provides an overview of strategic purchasing of nutrition services within primary health care. It introduces key terms and payment methods for countries to use in preparing to transform their health financial systems to scale up nutrition services. It does so by introducing nutritional...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
Cholera which disproportionally impacts poor countries and the most vulnerable continues to affect at least 47 countries across the globe, resulting in an estimated 1.3 – 4 million cases, and 21,000 - 143,000 deaths per year worldwide. In Ethiopia, despite major improvements seen in the increasing...
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ...
This is an e-learning module with the objective of providing education for health professionals and pregnant women using published results and studies based on COVID-19 surveillance data, which have indicated an increased risk among pregnant women of presenting with severe forms of COVID-19 and, the...
Leptospirosis is a zoonotic disease with epidemic potential, especially after a heavy rainfall,
caused by a bacterium called Leptospira. Leptospira interrogans is pathogenic to humans and
animals, with more than 200 serologic variants or serovars. Humans usually acquire
leptospirosis through dire...
Leptospirosis is an infectious disease caused by pathogenic organisms belonging to the genus Leptospira, that are transmitted directly or indirectly from animals to humans. Leptospirosis is a major direct zoonosis. Humanto-human transmission occurs only very rarely.
Snakebite is an acute life threatening time limiting medical emergency. It is a preventable public
health hazard often faced by rural population in tropical and subtropical countries with heavy
rainfall and humid climate.
Rabies is a devastating and societally important zoonotic disease, which is transmitted principally to humans through the bite of infected dogs. This acute, progressive viral encephalitis has the highest case fatality of any infectious disease and kills tens of thousands of people annually, with chi...
Human rabies remains a significant public health problem in Africa with outbreaks reported in most countries. In Nigeria–the most populous country in Africa–rabies causes a significant public health burden partly due to perennial obstacles to implementing a national prevention and control progra...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
WHO strongly recommends discontinuation of the nerve tissue vaccine, and replacement with modern concentrated and purified cell culture derived vaccines (CCDV) and embryonated eggbased rabies vaccines.
These vaccines must comply with WHO criteria for potency and innocuity following satisfactory ass...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
